TABLE 2.
Measurement method | Strengths | Weaknesses | Recommendation |
---|---|---|---|
Self-report w/standardized instruments | Inexpensive, easy to administer, can determine reasons for nonadherence and lead to intervention planning, represents patients’ experience/views; can assess multiple elements of the posttransplant medication regimen, including medication-taking, clinic appointment attendance, completion of blood work, following diet and exercise requirements, use of substances (eg, alcohol, tobacco), and any other monitoring requirements (eg, blood pressure, temperature, lung function) | May be less sensitive, specific, or precise than desired, subject to desirability response bias and recall bias; in the case of medication adherence, does not assess key components of medication-taking execution, for example taking, timing, or drug holidays | We recommend use of a self (patient)-reported standardized instrument that indicates reasons for nonadherence (eg, intentional or unintentional). Efforts should be made to reduce bias in reporting, such as explaining to the patient that it may be difficult to stay totally adherent to all prescribed regimen components |
Provider report | Inexpensive, easy to administer, can determine reasons for nonadherence and lead to intervention planning | May be less sensitive, specific, or precise than desired, subject to bias due provider misperceptions; often underestimates nonadherence; in the case of medication adherence, does not assess key components of medication-taking execution, for example taking, timing, or drug holidays | We do not recommend the sole use of provider reports |
Medication refill reportsa | Not subject to reporting bias, potentially accurate, potentially inexpensive | Indirect measure—pills obtained by patients may not have been taken, not taken on time, and/or not taken for multiple days (ie, drug holiday), clinics may not have access to all pharmacies used by their patients to obtain refill records, may not reflect dose changes | We recommend use of refill reports if a clinic has resources in place to access these metrics |
Medication blood levelsa | Direct measure of whether medication has been taken | Potentially difficult or expensive to implement, relatively intrusive to patient; only reflects adherence within a few days prior to level (ie, skipped for multiple days drug holiday); potentially less accurate because many factors other than adherence impact blood level results | We recommend use of blood levels if a clinic has resources in place to collect blood samples and data |
Electronic medication event monitoring devicesa | Can provide precise determination of concordance between pills used and prescribed regimen (eg, taking, timing, drug holidays), continuously records pill usage over desired time period and can quantify length of gaps between pills used, not subject to reporting bias | Expensive to obtain, potentially difficult and costly to implement by providers and use by patients, indirect measure—pills removed from device by patient may not have been taken; patients often only willing to use for short periods of time and do not see these devices as suitable replacements for weekly pill boxes for all medications | Recommended if a clinic has resources in place to purchase and implement these devices |
Electronic medical record review of adherence behavior (eg, clinic appointments, laboratories completed) | Can provide data on appointment and laboratory testing adherence; easily accessible by transplant staff; adherence assessment can be performed quickly | Requires access to electronic medical record | We recommend that this method should be implemented for laboratory tests and clinic visits |
Remote spirometry monitoring (in lung transplantation) | Can provide precise determination of spirometry use; not subject to reporting bias | Potentially difficult to implement by providers and for use by patients, indirect measure | We recommend this method as a complement to patient report if a clinic has resources to commit to its use |
Other biological assays (eg, smoking, alcohol use indicators) | Direct measure of whether prohibited substances have been used | Potentially difficult or expensive to implement, relatively intrusive to patient | We recommend this method as a complement to patient report if a clinic has resources to commit to its use |
Only applicable to medication adherence.